Marshall Islands vs South-East Asia (WHO region): Prevalence of diabetes, age-standardized
Marshall Islands
29.58
in 2022
South-East Asia (WHO region)
21.12
in 2022
Marshall Islands rank
4th
South-East Asia (WHO region) rank
2nd
Prevalence of diabetes, age-standardized over time
- Marshall Islands
- South-East Asia (WHO region)
How they compare
Marshall Islands currently reports 29.58 against 21.12 in South-East Asia (WHO region), a difference of 8.46.
That makes Marshall Islands's figure about 1.4 times South-East Asia (WHO region)'s.
Across all 33 years both countries report, Marshall Islands has been ahead every year.
Marshall Islands ranks 4th and South-East Asia (WHO region) ranks 2nd of 198 countries.
Marshall Islands has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Marshall Islands | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 28.7 | 11.47 | 17.22 | Marshall Islands |
| 2000s | 34.16 | 13.99 | 20.18 | Marshall Islands |
| 2010s | 32.82 | 17.05 | 15.77 | Marshall Islands |
| 2020s | 30 | 20.46 | 9.55 | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of diabetes, age-standardized, Marshall Islands or South-East Asia (WHO region)?
- Marshall Islands, at 29.58 against 21.12 in South-East Asia (WHO region) as of 2022.
- What is the difference in prevalence of diabetes, age-standardized between Marshall Islands and South-East Asia (WHO region)?
- 8.46, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and South-East Asia (WHO region)?
- 33 years are reported by both, from 1990 to 2022.
- How do Marshall Islands and South-East Asia (WHO region) rank globally for prevalence of diabetes, age-standardized?
- Marshall Islands ranks 4th and South-East Asia (WHO region) ranks 2nd of 198 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Prevalence of diabetes, age-standardized. Statizoid refreshes it automatically from the source and publishes the full history for both places.